| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 67.82× | 67.82× | 68.69× | 66.05× | 59.84× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.63× | 3.49× | 3.00× | 3.03× | 4.63× | ||
| 1.17× | 1.17× | 1.14× | 1.17× | 1.20× | ||
| 1.15× | 1.15× | 1.33× | 0.96× | 0.93× | ||
| 0.80× | 0.80× | 0.91× | 0.69× | 0.64× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 59.84 | 66.05 | 68.69 | 67.82 | 67.82 | |
| Working Capital Turnover | 4.63 | 3.03 | 3.00 | 3.49 | 3.63 | |
| Asset Turnover | 1.20 | 1.17 | 1.14 | 1.17 | 1.17 | |
| Cash Conversion (CFO/Net Income) | 0.93 | 0.96 | 1.33 | 1.15 | 1.15 | |
| CFO/EBITDA | 0.64 | 0.69 | 0.91 | 0.80 | 0.80 |